Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

COVID-19 in North America

National Association of Medicaid Directors (NAMD) Fall Conference 2026

Abt Global is a Sapphire sponsor of the NAMD 2026 Fall Conference. Find our Medicaid policy and data team at Booth 122.

Learn More
Event

APHSA Economic Mobility & Well-Being Conference 2026

Work requirements are expanding and budgets are not. Let's build an employment program that meets you where you're at.

Learn More
Event

Spotlight On: Digital Solutions for Environment and Natural Resources

We combine topical expertise, environmental science, data analytics, & engineering to help agencies modernize systems & use data to support better decisions.

Learn More
Spotlight On

2026 Defense Health Information Technology Symposium (DHITS)

Readiness is a data problem. We have solutions. Book a demo of our defense health data tools and meet our military health team. 

Learn More
Event